The first episode of our 2025 podcast series covers Semaglutides, a diabetes control drug that works by activating glucagon-like peptide-1 (GLP-1) receptors to suppress appetite.
Information
- Show
- PublishedApril 22, 2025 at 11:05 AM UTC
- Length34 min
- RatingClean